Confirming SAP results with further test is the best way to diagnose VF abnormalities

Article

It is best to confirm visual field (VF) abnormality as shown by Standard Automated Perimetry (SAP) with either a further SAP test or a Short-Wavelength Automated Perimetry (SWAP) test, concluded a study published in the March 2009 issue of Investigative Ophthalmology and Visual Science.

It is best to confirm visual field (VF) abnormality as shown by Standard Automated Perimetry (SAP) with either a further SAP test or a Short-Wavelength Automated Perimetry (SWAP) test, concluded a study published in the March 2009 issue of Investigative Ophthalmology and Visual Science.

Professor Robert Weinreb of the Hamilton Glaucoma Center and Department of Ophthalmology, University of California at San Diego, US and colleagues evaluated data from glaucomatous (n=174) and healthy (n=164) eyes, each with reliable 24-2 SAP-SITA, SWAP-SITA and Matrix FDT tests. The researchers created three definitions of VF abnormality: single-test abnormality, abnormality as confirmed by repeating the same test, and abnormality as confirmed by conducting a second, different, test. Using these three abnormality definitions, the team assessed each test’s sensitivity, the agreement between tests, the deficit locations and machine-generated pattern standard deviation (PSD) to compare the testing methods.

Professor Weinreb’s team discovered that single tests of SAP, SWAP and FDT had sensitivities of 30%, 29% and 28%, respectively. When confirming the abnormality with the same test, sensitivities were 24–27%; when confirming with a different test, the sensitivity range was 20–23%. The sensitivities of the combinations of different tests were all lower than the SAP/SAP test, and the sensitivities of the same-tests were higher than that of the SWAP/FDT test.

Therefore the team concluded that it is important to confirm a diagnosis of VF abnormality on SAP by subsequently testing again, either with SAP or SWAP.

Recent Videos
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
3 experts are featured in this series.
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Sunita Radhakrishnan, MD, an associate at the Glaucoma Center of San Francisco, speaks at the annual Glaucoma 360 meeting about electrical neurostimulation.
3 experts are featured in this series.
3 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.